Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by CUIN23on Jan 19, 2018 7:37am

174 Views

Post# 27392046

This appears to be an Aedemic Stock

Scientists and academics have benefited greatly from the ongoing and continual research with Theralase and its various PDC’s. Investors, not so much.

You have to ask yourself why that is.

Posters like Bencro, dispite constant scientific posting about PDC’s, haven’t helped raise the PPS here in how many years?

Bullboard Posts

This battery metals stock is on a path to the global stage